Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipids as Anchors01:32

Lipids as Anchors

5.9K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.9K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

260
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
260
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

31.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
31.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the structure of swine leukocyte antigen class I molecules.

Cellular & molecular biology letters·2026
Same author

Halogenation engineered metal cluster assemblies.

National science review·2026
Same author

Water-Triggered Structural Transformation in a Silver Chalcogenolate Cluster-Based MOF (SCC-MOF) Enables Visually Readable Trace Water Sensing.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Optimized digital polymerase chain reaction enables detection of telomerase reverse transcriptase C228T mutation for prognostic assessment in hepatocellular carcinoma.

World journal of gastrointestinal oncology·2026
Same author

The causal relationship between body mass index and perianal abscess: a Mendelian randomization study.

BMC gastroenterology·2025
Same author

Current state of knowledge about African swine fever: a review.

Animal health research reviews·2025

Related Experiment Video

Updated: Sep 13, 2025

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
08:26

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death

Published on: October 31, 2017

9.4K

Fatty acid-binding proteins in cancers.

Long Wu1,2, Guang-Ling Ou3, Wei Zhang3

  • 1Department of Colorectal Cancer Center, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou Province, China.

International Journal of Surgery (London, England)
|July 28, 2025
PubMed
Summary

Fatty acid-binding proteins (FABPs) are key regulators in cancer, influencing metabolism, immune response, and treatment resistance. Understanding their diverse roles is crucial for developing targeted cancer therapies.

Keywords:
cancerclinical significancefatty acid-binding proteinsmechanismsresearch progressreview

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

658
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.3K

Related Experiment Videos

Last Updated: Sep 13, 2025

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
08:26

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death

Published on: October 31, 2017

9.4K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

658
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.3K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Fatty acid-binding proteins (FABPs) are intracellular chaperones (14-15 kDa) that bind and transport lipids.
  • FABPs play critical roles in metabolic regulation, signal transduction, and gene expression, impacting cancer initiation and progression.
  • Eleven FABP subtypes (FABP1-FABP12) show tissue-specific expression and influence tumor progression via metabolic reprogramming, immune modulation, and therapy resistance.

Purpose of the Study:

  • To review the multifaceted roles of FABPs in cancer development and progression.
  • To highlight FABP-mediated mechanisms in metabolic reprogramming, immune microenvironment modulation, and therapy resistance.
  • To discuss the clinical implications of FABPs as diagnostic biomarkers and therapeutic targets, acknowledging current challenges.

Main Methods:

  • Literature review and synthesis of existing research on FABP functions in various cancer types.
  • Analysis of FABP roles in cellular metabolism, including fatty acid uptake, oxidation, and synthesis.
  • Examination of FABP involvement in immune cell function and tumor microenvironment modulation.
  • Investigation of FABP contributions to therapeutic resistance, including chemoresistance and apoptosis evasion.
  • Review of clinical applications and challenges associated with FABP-targeted therapies.

Main Results:

  • FABPs significantly impact tumor metabolism, supporting high proliferative demands through enhanced fatty acid processes.
  • Specific FABPs modulate the immune microenvironment; for instance, FABP4+ macrophages secrete IL-6, and FABP6 downregulates MHC-I, promoting immunosuppression.
  • FABPs contribute to therapy resistance: FABP4 promotes survival in ovarian cancer, and FABP5 confers chemoresistance in HCC.
  • Functional heterogeneity exists, with FABP7 driving glioblastoma migration and FABP5 having context-dependent roles in HCC and CRC.
  • FABPs show clinical potential as biomarkers and therapeutic targets, but challenges like specificity and toxicity persist.

Conclusions:

  • FABPs are central regulators in cancer, influencing key processes from initiation to therapy resistance.
  • Targeting FABPs offers potential for novel cancer diagnostics and therapeutics, but subtype-specific functions and heterogeneity must be addressed.
  • Future research integrating multi-omics and single-cell technologies is essential for precise, clinically translatable combination therapies.